Michael Santoro : Speedy Drug Approvals and Pharmaceutical Regulations : LA Times
Michael Santoro, professor of management and co-editor of the book Ethics and the Pharmaceutical Industry, offered insight on President Trump’s proposals to deregulate the drug industry. The article sought to reconcile Trump’s seemingly paradoxical statements that his administration was planning on both eliminating regulations and increasing consumer protection.
“We need regulations to make sure first and foremost that there’s drug safety and efficacy,” he said.
An excerpt from the article:
What Trump is basically proposing is less testing of drugs before they’re made available to patients.
“The pharmaceutical industry is a business and wants to bring drugs to the market quickly,” Santoro said. “That’s why you need the Food and Drug Administration to look at the medical and scientific evidence to make sure that speeding up the process doesn’t harm the public.”
Read the full article here»
Learn more about Michael Santoro here»